Gullestad L, Myers J, Ross H, Rickenbacher P, Slauson S, Bellin D, Do D, Vagelos R, Fowler M
Falk Cardiovascular Research Center, Stanford University School of Medicine, CA, USA.
Am Heart J. 1998 Feb;135(2 Pt 1):221-9. doi: 10.1016/s0002-8703(98)70085-7.
This study sought to examine the predictive value of variables obtained from serial maximal exercise testing, echocardiography, and ejection fraction in patients referred as potential heart transplant candidates.
Variables such as peak VO2, left ventricular dimensions, ejection fraction, and hemodynamic measurements are known to predict prognosis in heart failure, but there are few data on the impact of serial measurements of these variables on subsequent mortality.
Two hundred sixty-three ambulatory patients with severe heart failure referred as potential candidates for heart transplantation who underwent two exercise tests (mean 7.8 months apart) after optimal medical treatment were identified. At the same two time points, echocardiography was performed in 106 (37%) and ejection fraction was measured in 84 (30%). During a mean follow-up period of 3.9+/-0.1 years, 70 (25%) died and 45 (19%) underwent heart transplantation. Exercise capacity, peak exercise heart rate, and peak exercise systolic blood pressure achieved were all significantly higher among survivors compared with nonsurvivors. Among the survivors a slight increase in peak VO2 and ejection fraction were observed, but there were no significant differences in the changes of any of the measured variables between survivors and nonsurvivors. There were no significant differences in survival between patients with increased versus those with decreased peak VO2, left ventricular dimensions, or ejection fraction.
Although peak VO2, left ventricular dimensions, and ejection fraction predict survival, changes in these parameters do not add any prognostic information in patients with severe heart failure who have been stabilized with optimal medical treatment. Routine use of these procedures therefore does not seem to be warranted and should be performed only in the context of a specific clinical situation. Serial measurements of these parameters do not appear to be useful in the risk stratification of patients referred for heart transplantation.
本研究旨在探讨从连续最大运动试验、超声心动图及射血分数获得的变量对被视为潜在心脏移植候选者的患者的预测价值。
诸如峰值摄氧量、左心室尺寸、射血分数及血流动力学测量等变量已知可预测心力衰竭的预后,但关于这些变量的连续测量对后续死亡率影响的数据较少。
确定了263例因严重心力衰竭而被视为潜在心脏移植候选者的门诊患者,这些患者在接受最佳药物治疗后进行了两次运动试验(平均间隔7.8个月)。在相同的两个时间点,106例(37%)患者接受了超声心动图检查,84例(30%)患者测量了射血分数。在平均3.9±0.1年的随访期内,70例(25%)患者死亡,45例(19%)患者接受了心脏移植。与非幸存者相比,幸存者的运动能力、运动峰值心率及运动峰值收缩压均显著更高。在幸存者中,观察到峰值摄氧量和射血分数略有增加,但幸存者与非幸存者之间任何测量变量的变化均无显著差异。峰值摄氧量、左心室尺寸或射血分数增加的患者与减少的患者之间的生存率无显著差异。
尽管峰值摄氧量、左心室尺寸和射血分数可预测生存率,但在已通过最佳药物治疗稳定病情的严重心力衰竭患者中,这些参数的变化并未增加任何预后信息。因此,常规使用这些检查似乎没有必要且仅应在特定临床情况下进行。这些参数的连续测量在被转诊进行心脏移植的患者的风险分层中似乎并无用处。